mhurhangee/ep-ind-claims huggingface dataset:
A swallow formulation comprising: a) a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of an amphoteric compound, b) one or more pH modulating agents wherein at least one pH modulating agent is sodium bicarbonate or potassium bicarbonate in an amount that will neutralise 0.01 to 9.0 millimoles of hydrochloric acid and is present in an amount from about 1% to about 50% by weight of the swallow formulation, the amount of said bicarbonate being from 1 to 199 mg per tablet, and c) a water uptake agent, wherein at least about 70% of the therapeutic compound is dissolved from the swallow formulation within 180 seconds in United States Pharmacopeia dissolution apparatus 2 with 900 mL 0.0033 N hydrochloric acid at 30 rpm and 37°C. a) a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of an amphoteric compound, b) one or more pH modulating agents wherein at least one pH modulating agent is sodium bicarbonate or potassium bicarbonate in an amount that will neutralise 0.01 to 9.0 millimoles of hydrochloric acid and is present in an amount from about 1% to about 50% by weight of the swallow formulation, the amount of said bicarbonate being from 1 to 199 mg per tablet, and c) a water uptake agent,
An in-vitro use of Bovine Meat and Milk Factor Group 1 (BMMF1) Rep Protein as a biomarker for prostate cancer, wherein the Rep protein is a MSBI1 genome-encoded Rep protein (MSBI1 Rep) encoded by MSBI1.176 comprising the amino acid sequence as depicted in SEQ ID NO: 1, a MSBI2 genome-encoded Rep protein (MSBI2 Rep) encoded by MSBI2.176 comprising the amino acid sequence as depicted in SEQ ID NO: 8, a CMI1 genome-encoded Rep protein (CMI1 Rep) encoded by CMI1.252 comprising the amino acid sequence as depicted in SEQ ID NO: 10, a CMI2 genome-encoded Rep protein (CMI2 Rep) encoded by CMI2.214 comprising the amino acid sequence as depicted in SEQ ID NO: 11, a CMI3 genome-encoded Rep protein (CMI3 Rep) encoded by CMI3.168 comprising the amino acid sequence as depicted in SEQ ID NO: 12, or a variant of the protein with SEQ ID NO: 1 or SEQ ID NO: 8 having a homology of at least 90%, wherein the variant has one or more amino acid deletions, substitutions or additions and is capable of binding an anti-Rep antibody specific for a Rep protein having the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 8.
A stent comprising: an elastically deformable body (210, 220) that has a predetermined diameter and length and is formed by interlacing wires in the form of a tube; a film part that surrounds to cover at least a portion of the body, extends a predetermined length from one end of the body, and is made of a flexible material; and an anti-inversion part that is connected to the one end of the body from which the film part extends, characterized in that the stent is configured to be placed in the bile duct to facilitate bile secretion into the duodenum the anti-inversion part is configured to prevent the film part from being inverted and folded inwardly toward the body to prevent digested food from the duodenum from entering the gallbladder, and the body is divided into a first region uncovered with the film part and a second region covered with the film part. an elastically deformable body (210, 220) that has a predetermined diameter and length and is formed by interlacing wires in the form of a tube; a film part that surrounds to cover at least a portion of the body, extends a predetermined length from one end of the body, and is made of a flexible material; and an anti-inversion part that is connected to the one end of the body from which the film part extends, characterized in that the stent is configured to be placed in the bile duct to facilitate bile secretion into the duodenum the anti-inversion part is configured to prevent the film part from being inverted and folded inwardly toward the body to prevent digested food from the duodenum from entering the gallbladder, and the body is divided into a first region uncovered with the film part and a second region covered with the film part.
A method of producing filler, comprising precipitated calcium carbonate,, which method comprises the steps of; - providing fly ash generated in paper or paper board production; - fractionating said fly ash in at least one step, whereby a coarser fraction is separated from a finer fraction; - grinding said coarser fraction to an average particle size of 20 μm or less; - forming a suspension of said grinded coarser fraction; - adding carbon dioxide to said suspension to form precipitated calcium carbonate. - providing fly ash generated in paper or paper board production; - fractionating said fly ash in at least one step, whereby a coarser fraction is separated from a finer fraction; - grinding said coarser fraction to an average particle size of 20 μm or less; - forming a suspension of said grinded coarser fraction; - adding carbon dioxide to said suspension to form precipitated calcium carbonate.
A microelectronic device, comprising: an upper substrate having a first surface; at least a first upper pad and a second upper pad located adjacent and separated from one other on the first surface; a lower substrate having a second surface spaced apart from the first surface with a gap between the first surface and the second surface (21, 31), the gap being about 5 microns or less; at least a first lower pad and a second lower pad located adjacent and separated from one other on the second surface; lower surfaces of the first and second upper pads being coupled respectively to upper surfaces of the first and second lower pads for electrical conductivity between the upper substrate and the lower substrate (20, 30); a first conductive collar around sidewalls (52, 42) of the first upper and lower pads and a second conductive collar around sidewalls (52, 42) of the second upper and lower pads (50, 40); and a first dielectric layer and a second dielectric layer conformal to and around the first conductive collar and the second conductive collar, respectively, wherein the first and second dielectric layers are spaced apart from one another. an upper substrate having a first surface; at least a first upper pad and a second upper pad located adjacent and separated from one other on the first surface; a lower substrate having a second surface spaced apart from the first surface with a gap between the first surface and the second surface (21, 31), the gap being about 5 microns or less; at least a first lower pad and a second lower pad located adjacent and separated from one other on the second surface; lower surfaces of the first and second upper pads being coupled respectively to upper surfaces of the first and second lower pads for electrical conductivity between the upper substrate and the lower substrate (20, 30); a first conductive collar around sidewalls (52, 42) of the first upper and lower pads and a second conductive collar around sidewalls (52, 42) of the second upper and lower pads (50, 40); and a first dielectric layer and a second dielectric layer conformal to and around the first conductive collar and the second conductive collar, respectively, wherein the first and second dielectric layers are spaced apart from one another.
A composition for use in therapy comprising: i) Trolox, Na +, K +, Ca 2+, Mg 2+, Cl -, H 2 PO 4 -, HEPES, lactobionate, sucrose, mannitol, glucose, dextran-40, adenosine and glutathione; and ii) human neural or mesenchymal stem cells or human retinal progenitor cells, wherein the composition does not include a dipolar aprotic solvent, in particular DMSO, and wherein the composition is suitable for storage at cryothermic temperatures and, following thawing, is suitable for direct administration to a patient without requiring further processing. i) Trolox, Na +, K +, Ca 2+, Mg 2+, Cl -, H 2 PO 4 -, HEPES, lactobionate, sucrose, mannitol, glucose, dextran-40, adenosine and glutathione; and ii) human neural or mesenchymal stem cells or human retinal progenitor cells, wherein the composition does not include a dipolar aprotic solvent, in particular DMSO, and wherein the composition is suitable for storage at cryothermic temperatures and, following thawing, is suitable for direct administration to a patient without requiring further processing.
Device, in particular a hair styling device with a handle region and a heatable working region, wherein the device is embodied in terms of its external shape and its centre of gravity such that it adopts a self-stabilising and self-uprighting position when placed down onto a base support, in which the heatable working region is not in contact with the base support, but even adopts a greatest possible distance therefrom, wherein the centre of gravity and the shape of the device are arranged or embodied such that the device functions similarly to a weeble, characterised in that the handle region has a semi-spherical or semi-ellipsoidal form or a gömböclike external shape.
An erecting aid for erecting a box from a box template, comprising: a generally planar table having a length extending between a proximal end and a distal end thereof; a panel coupled to a side of said generally planar table at least partially between said proximal end and said distal end of said generally planar table; and a clamp operatively associated with said generally planar table, wherein said clamp is biased towards a closed position and is at least partially movable along the length of said generally planar table between said proximal end and said distal end of said generally planar table, said clamp comprising: a first clamp portion secured in a stationary position relative to said generally planar table; and a second clamp portion, said second clamp portion being moveable between said proximal end and said distal end of said generally planar table, said second clamp portion being biased towards said first clamp portion in a manner that creates a clamping force between said first clamp portion and said second clamp portion; wherein said generally planar table, said panel, and said clamp are configured to stabilize and maintain a box template in a partially assembled state during an erecting process that occurs on said generally planar table. a generally planar table having a length extending between a proximal end and a distal end thereof; a panel coupled to a side of said generally planar table at least partially between said proximal end and said distal end of said generally planar table; and a clamp operatively associated with said generally planar table, wherein said clamp is biased towards a closed position and is at least partially movable along the length of said generally planar table between said proximal end and said distal end of said generally planar table, said clamp comprising: a first clamp portion secured in a stationary position relative to said generally planar table; and a second clamp portion, said second clamp portion being moveable between said proximal end and said distal end of said generally planar table, said second clamp portion being biased towards said first clamp portion in a manner that creates a clamping force between said first clamp portion and said second clamp portion; a first clamp portion secured in a stationary position relative to said generally planar table; and a second clamp portion, said second clamp portion being moveable between said proximal end and said distal end of said generally planar table, said second clamp portion being biased towards said first clamp portion in a manner that creates a clamping force between said first clamp portion and said second clamp portion; wherein said generally planar table, said panel, and said clamp are configured to stabilize and maintain a box template in a partially assembled state during an erecting process that occurs on said generally planar table.
Apparatus for the provision of topical negative pressure therapy to a wound, the apparatus including: a waste canister into which fluid is aspirated from a wound by aspiration pump means and a fluid flow path for at least a part of said aspirated fluid on an outlet side of said aspiration pump means wherein said fluid flow path on the outlet side comprises a silencing system having a plurality of silencing elements therein, said silencing system comprising at least one exhaust conduit portion and a plenum chamber, wherein said plenum chamber contains sound absorbing material and characterised in that said plenum chamber has an open face sealed closed by an outer casing member of the apparatus.
A process for the epoxidation of an olefin by continuously reacting the olefin with hydrogen peroxide in a methanol solvent on a fixed bed epoxidation catalyst comprising a titanium zeolite, characterized in that hydrogen peroxide is used as an aqueous hydrogen peroxide solution made by an anthraquinone process, the aqueous hydrogen peroxide solution is mixed with methanol to give a feed mixture and said feed mixture is filtered before being contacted with the fixed bed epoxidation catalyst.
A chitosan-containing polysaccharide obtained from fungi as a starting material, for use in a method for treating or preventing a disease originated from living habits or customs wherein the disease is hypertension or diabetes, wherein the chitosan-containing polysaccharide has characteristic properties specified below: Constituent Saccharides: The polysaccharide comprises glucosamine and glucose and the molar ratio thereof ranges from 1:5 to 5:1; Molecular Weight: The molecular weight thereof as determined according to the viscometric technique using an Ostwald viscometer ranges from about 50,000 to about 400,000; Structural Units: The polysaccharide is mainly composed of chitosan moieties and glucan moieties; Kinds of Linkages: The polysaccharide does not contain any β (1→3) bonds, but it comprises β(1→4) bonds and β(1→6) bonds; Hydrolyzation with Enzyme: The polysaccharide is not hydrolyzed with a cellulanase, but is hydrolyzed into oligosaccharides by the action of a chitosanase; Proteins and Reducing Polysaccharides: The polysaccharide is free of any protein and reducing polysaccharide; Color Reaction: It is negative to the iodostarch reaction; Color of the Substance: It is colorless (or it has a white color); Solubility: It is soluble in an aqueous acetic acid, malic acid or ascorbic acid solution having a concentration ranging from 5 to 10% by mass, but it is insoluble in water, ethanol and an alkaline aqueous solution having a pH value of not less than 10. Constituent Saccharides: The polysaccharide comprises glucosamine and glucose and the molar ratio thereof ranges from 1:5 to 5:1; Molecular Weight: The molecular weight thereof as determined according to the viscometric technique using an Ostwald viscometer ranges from about 50,000 to about 400,000; Structural Units: The polysaccharide is mainly composed of chitosan moieties and glucan moieties; Kinds of Linkages: The polysaccharide does not contain any β (1→3) bonds, but it comprises β(1→4) bonds and β(1→6) bonds; Hydrolyzation with Enzyme: The polysaccharide is not hydrolyzed with a cellulanase, but is hydrolyzed into oligosaccharides by the action of a chitosanase; Proteins and Reducing Polysaccharides: The polysaccharide is free of any protein and reducing polysaccharide; Color Reaction: It is negative to the iodostarch reaction; Color of the Substance: It is colorless (or it has a white color); Solubility: It is soluble in an aqueous acetic acid, malic acid or ascorbic acid solution having a concentration ranging from 5 to 10% by mass, but it is insoluble in water, ethanol and an alkaline aqueous solution having a pH value of not less than 10.
A chair comprising: an upper base unit and a lower base unit facing each other, at least one of the upper base unit and the lower base unit including a rolling surface (312a, 322a) being curved; and a seat that is provided in the upper base unit and swings when the upper base unit rolls with respect to the lower base unit, wherein a region having a different curvature exists in a part of the rolling surface (312a, 322a), and an elastic member is interposed between the region having the different curvature and a corresponding region of an opposing surface; wherein the chair further comprises a connection member (34, 35, 36) that connects the upper base unit and the lower base unit, wherein the region having the different curvature is a relief hole (31P, 32P, 31Q, 32Q) for inserting the connection member (34, 35, 36); wherein the upper base unit swings in a direction of 360 degrees with respect to the lower base unit, and the relief hole is provided at three or more locations around a swing center; wherein the connection member (34, 35, 36) is a rotation stop member that restricts a relative movement of the upper base unit and the lower base unit in a rotation direction; and wherein the elastic member is an elastic resin foam body interposed between the upper base unit and the lower base unit. an upper base unit and a lower base unit facing each other, at least one of the upper base unit and the lower base unit including a rolling surface (312a, 322a) being curved; and a seat that is provided in the upper base unit and swings when the upper base unit rolls with respect to the lower base unit, wherein a region having a different curvature exists in a part of the rolling surface (312a, 322a), and an elastic member is interposed between the region having the different curvature and a corresponding region of an opposing surface; wherein the chair further comprises a connection member (34, 35, 36) that connects the upper base unit and the lower base unit, wherein the region having the different curvature is a relief hole (31P, 32P, 31Q, 32Q) for inserting the connection member (34, 35, 36); wherein the upper base unit swings in a direction of 360 degrees with respect to the lower base unit, and the relief hole is provided at three or more locations around a swing center; wherein the connection member (34, 35, 36) is a rotation stop member that restricts a relative movement of the upper base unit and the lower base unit in a rotation direction; and wherein the elastic member is an elastic resin foam body interposed between the upper base unit and the lower base unit.
A method of controlling power usage in a battery powered device, the device being a peripheral of a security monitoring system, the device including a battery power supply, the method comprising: determining an initial energy capacity of the battery power supply based on an identification of the battery power supply; and based on the determination of the initial energy capacity of the battery power supply, selecting operating parameters of elements of the device to control power usage of the device to achieve a desired lifetime for the battery power supply. determining an initial energy capacity of the battery power supply based on an identification of the battery power supply; and based on the determination of the initial energy capacity of the battery power supply, selecting operating parameters of elements of the device to control power usage of the device to achieve a desired lifetime for the battery power supply.
A parameter adjustment method for adjusting a control parameter of a motor control section controlling a servomotor (10, 20, 30) used in a drive system for a machine tool in which the servomotor (10, 20, 30) feeds a workpiece or a tool, and in which a processor is connected to the motor control section; characterized in that the method includes the steps of: acquiring a servo gain basic parameter (P 0) in advance through calculation or manual adjustment, in a state with a reference load having a reference inertia (I 0) acting on the servo motor (10, 20, 30) used in the drive system; and in a parameter adjustment mode while rotating a load by the servomotor (10, 20, 30) with a given speed command issued to the motor control section under a condition where torque is limited, the processor calculating load inertia (I 1) based on the limited torque and an angular acceleration of the servomotor (10, 20, 30) that is obtained based on an output from the servomotor (10, 20, 30), calculating a servo gain parameter (P 1) based on P 1 = P 0 ×(1+C×I 1 /I 0), where P 0 denotes the servo gain basic parameter, C denotes a correction coefficient, I 0 denotes the reference inertia, and adjusting the control parameter set to the motor control section based on the servo gain parameter (P 1) acquiring a servo gain basic parameter (P 0) in advance through calculation or manual adjustment, in a state with a reference load having a reference inertia (I 0) acting on the servo motor (10, 20, 30) used in the drive system; and in a parameter adjustment mode while rotating a load by the servomotor (10, 20, 30) with a given speed command issued to the motor control section under a condition where torque is limited, the processor calculating load inertia (I 1) based on the limited torque and an angular acceleration of the servomotor (10, 20, 30) that is obtained based on an output from the servomotor (10, 20, 30), calculating a servo gain parameter (P 1) based on P 1 = P 0 ×(1+C×I 1 /I 0), where P 0 denotes the servo gain basic parameter, C denotes a correction coefficient, I 0 denotes the reference inertia, and adjusting the control parameter set to the motor control section based on the servo gain parameter (P 1)
A vibration damping device for a tub of a washing or drying machine also comprising a housing, the device comprising: a first articulating piece, provided to be connected to the tub in an articulated manner by means of a first articulation that allows rotation about a first rotation axis, and connected to a second articulating piece in an articulated manner by means of a second articulation that allows rotation about a second rotation axis, and the second articulating piece being provided to be connected to the housing in an articulated manner by means of a third articulation that allows rotation about a third rotation axis, in which at least one from the first articulation, the second articulation and the third articulation is an articulation that provides frictional resistance to rotation, characterized in that the distance between the rotation axes of an articulating piece is variable by extending or contracting one of the articulating pieces, while there is no rotatory movement in the articulation(s) that provide frictional resistance to rotation.
A method for displaying a video, comprising: receiving, by a video management system, a video stream including a plurality of image frames, wherein at least some image frames include an overlay; determining, by the video management system, a position of the overlay within an image frame; applying, by the video management system, an image adjustment function to the image frame to create an adjusted image frame, wherein the image adjustment function uses the determined position of the overlay to adjust the image while keeping the appearance of the overlay essentially unchanged by copying the overlay from the image frame, spatially rearranging pixels of the image frame, and inserting the copied overlay into the image frame with the spatially rearranged pixels, or by spatially rearranging pixels of the image frame that do not form part of the overlay,; and displaying the video stream including the adjusted image frame. receiving, by a video management system, a video stream including a plurality of image frames, wherein at least some image frames include an overlay; determining, by the video management system, a position of the overlay within an image frame; applying, by the video management system, an image adjustment function to the image frame to create an adjusted image frame, wherein the image adjustment function uses the determined position of the overlay to adjust the image while keeping the appearance of the overlay essentially unchanged by copying the overlay from the image frame, spatially rearranging pixels of the image frame, and inserting the copied overlay into the image frame with the spatially rearranged pixels, or by spatially rearranging pixels of the image frame that do not form part of the overlay,; and displaying the video stream including the adjusted image frame.